304 filings
Page 6 of 16
6-K
3a5qrj5zh jtxx5
19 Apr 18
Current report (foreign)
12:00am
6-K
08s1c3sx
19 Apr 18
Current report (foreign)
12:00am
6-K
ffsjkzdx1g oiu
6 Apr 18
Current report (foreign)
12:00am
6-K
el736oowbzy0z p9
3 Apr 18
Current report (foreign)
12:00am
6-K
660plj9k5 zxb
14 Mar 18
GW Pharmaceuticals Announces Results of Annual General Meeting
12:00am
6-K
l499u 6ke
14 Mar 18
Current report (foreign)
12:00am
6-K
7yk2akui2ui
13 Mar 18
Current report (foreign)
12:00am
6-K
kuxefuyps
6 Mar 18
Current report (foreign)
12:00am
6-K
qj2y2i8y4okrh44 4kab
23 Feb 18
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006
12:00am
SC 13G/A
1lt35sl0q 8tic
14 Feb 18
GW Pharmaceuticals PLC
12:00am
6-K
xce6pb
14 Feb 18
Current report (foreign)
12:00am
SC 13G/A
esjpi
14 Feb 18
Beneficial ownership report (amended)
12:00am
SC 13G/A
437ummy usr2wog
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G
vrxmvirkz5d
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G/A
7e2k65pwiy3ynno7
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G/A
6h6gk2blbj hcf
13 Feb 18
GW Pharmaceuticals PLC
12:00am
6-K
rfsmj2qtliavx5
5 Feb 18
GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress
12:00am
6-K
uxcwf zcyb
8 Jan 18
Current report (foreign)
12:00am
CT ORDER
x2e5vp
21 Dec 17
Confidential treatment order
12:00am
6-K
a8540
12 Dec 17
GW Pharmaceuticals Announces Proposed Public Offering of ADSs
12:00am